- Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1. Ayyoub, M., Zippelius, A., Pittet, M.J., Rimoldi, D., Valmori, D., Cerottini, J.C., Romero, P., Lejeune, F., Liénard, D., Speiser, D.E. Clin. Cancer Res. (2003)